Vosevi
My Prescription
Payment
Select pharmacy
$25,517.61
Print or send this coupon to your phone
WalgreensPowered byPay as little as $0 for Vosevi
Works with your insurance. Enroll in the manufacturer's savings program in a few steps.
About Vosevi
Drug Details
Vosevi is a medication composed of three antiviral drugs: sofosbuvir, velpatasvir, and voxilaprevir. It is used to treat chronic hepatitis C, a persistent viral infection affecting the liver. Vosevi is particularly recommended for adults who have previously undergone treatment but have not been cured, specifically for those with hepatitis C genotypes 1, 2, 3, 4, 5, or 6, or for those with genotype 1a or 3 who were treated with sofosbuvir without an NS5A inhibitor. This medication works by lowering the amount of hepatitis C virus in the body, aiding the immune system in combatting the infection, and potentially aiding liver recovery. While taking Vosevi, it is crucial to continue practicing safe behaviors, such as not sharing needles and using latex condoms, to reduce the risk of transmitting the virus to others. The treatment is taken once daily, though it may occasionally cause headaches. It's important to consult with a healthcare provider for personalized medical advice before starting any new treatment.
Price history for Vosevi
28 Tablets, 400-100-100MG
Average retail price for Vosevi
Average SaveHealth price for Vosevi
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Vosevi dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 400-100-100MG | 28 Tablets | $25,725.44 | $918.77 |
Vosevi FAQs
Vosevi is used for the treatment of chronic hepatitis C virus (HCV) infection in adults. It is typically prescribed for patients who have previously been treated with other HCV medications but did not achieve a sustained virologic response.
Vosevi and Epclusa are both antiviral medications used to treat chronic hepatitis C virus (HCV) infection, but they differ in their composition and specific use cases.Vosevi is a combination of three antiviral agents: sofosbuvir, velpatasvir, and voxilaprevir. It is typically used for patients who have previously been treated with other HCV medications but did not achieve a sustained virologic response.Epclusa, on the other hand, is a combination of two antiviral agents: sofosbuvir and velpatasvir. It is used for the treatment of HCV in patients who are either treatment-nave or have been treated before, and it is effective across all major genotypes of the virus.The choice between these medications depends on the patient's treatment history and specific HCV genotype.
The cost of Vosevi can vary depending on factors such as the pharmacy, location, and insurance coverage. Without insurance, the price for a 28-day supply can be several thousand dollars. It is advisable for individuals to check with their pharmacy or insurance provider for the most accurate and up-to-date pricing information.
Vosevi is an antiviral medication used to treat chronic hepatitis C virus (HCV) infection. It is effective in curing the infection in many cases, particularly in patients who have not responded to other treatments. However, the success of the treatment can depend on various factors, including the specific genotype of the virus and the patient's overall health. It is important for patients to follow their healthcare provider's instructions and complete the full course of treatment to achieve the best possible outcome.
A substitute for Vosevi, which is used to treat chronic hepatitis C, would depend on the specific genotype of the hepatitis C virus and the patient's medical history. Alternatives may include other direct-acting antiviral medications such as Harvoni (ledipasvir/sofosbuvir), Epclusa (sofosbuvir/velpatasvir), or Mavyret (glecaprevir/pibrentasvir). It is important for the patient to consult with a healthcare provider to determine the most appropriate treatment option based on their individual circumstances.